Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health In Tech (HIT) Gains from Investment Securities (2023 - 2025)

Health In Tech has reported Gains from Investment Securities over the past 3 years, most recently at $7403.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $7403.0 for Q4 2025, down 96.6% from a year ago — trailing twelve months through Dec 2025 was $526689.0 (down 5.7% YoY), and the annual figure for FY2025 was $193284.0, changed.
  • Gains from Investment Securities for Q4 2025 was $7403.0 at Health In Tech, down from $1.3 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for HIT hit a ceiling of $2.3 million in Q2 2025 and a floor of $7403.0 in Q4 2025.
  • Median Gains from Investment Securities over the past 3 years was $251993.0 (2024), compared with a mean of $797061.0.
  • Peak annual rise in Gains from Investment Securities hit 8354.6% in 2025, while the deepest fall reached 96.6% in 2025.
  • Health In Tech's Gains from Investment Securities stood at $2.2 million in 2023, then tumbled by 90.19% to $217734.0 in 2024, then plummeted by 96.6% to $7403.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $7403.0 (Q4 2025), $1.3 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.